PDF-Magenta Therapeutics
1
MGTA 145 in Combination with Plerixafor Rapidly Mobilizes Large Numbers of HSCs in Humans That Can Be Gene Edited with CRISPRCas9 and Mediate Superior Engraftment
Download Presentation
"Magenta Therapeutics" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.